General Information
Drug ID
DR00461
Drug Name
Thalidomide
Synonyms
(+)-Thalidomide; (+-)-Thalidomide; (+/-)-THALIDOMIDE; (inverted question mark)-Thalidomide; 2,6-Dioxo-3-phthalimidopiperidine; 3-Phthalimidoglutarimide; Algosediv; Alpha-(N-Phthalimido)glutarimide; Alpha-N-Phthalylglutaramide; Alpha-Phthalimidoglutarimide; Asidon 3; Asmadion; Asmaval; Bonbrain; Bonbrrin; Calmore; Calmorex; Celgene Brand of Thalidomide; Contergan; Corronarobetin; Distaval; Distaxal; Distoval; E-217; ENMD 0995; Ectiluran; Enterosediv; Gastrinide; Glupan; Glutanon; Grippex; Hippuzon; IN1061; Imida-lab; Imidan (peyta); Imidene; Isomin; K 17; K-17; Kedavon; Kevadon; N-(2,6-Dioxo-3-piperidyl)phthalimide; N-Phthalimidoglutamic acid imide; N-Phthaloylglutamimide; N-Phthalyl-glutaminsaeure-imid; N-Phthalyl-glutaminsaeure-imid [German]; N-Phthalylglutamic acid imide; Neaufatin; Neosedyn; Neosydyn; Nerosedyn; Neufatin; Neurodyn; Neurosedin; Neurosedym; Neurosedyn; Nevrodyn; Nibrol; Noctosediv; Noxodyn; Pangul; Pantosediv; Poly-Giron; Polygripan; Predni-Sediv; Pro-Bam M; Pro-ban M; Profarmil; Psycholiquid; Psychotablets; Quetimid; Quietoplex; Sandormin; Sedalis; Sedalis sedi-lab; Sedimide; Sedin; Sedisperil; Sedoval; Shin-naito S; Shinnibrol; Sleepan; Slipro; Softenil; Softenon; Synovir; THALIDOMIDE (AIDS INITIATIVE); Talargan; Talidomida; Talidomida [INN-Spanish]; Talidomide; Talidomide [DCIT]; Talimol; Talismol; Talizer; Telagan; Telargan; Telargean; Tensival; Thaled; Thaled (TN); Thalidomide (+ and-); Thalidomide (JAN/USP/INN); Thalidomide (soluble form); Thalidomide Celgene; Thalidomide Pharmion; Thalidomide [USAN:INN:BAN]; Thalidomidum; Thalidomidum [INN-Latin]; Thalidomine USP26; Thalin; Thalinette; Thalomid; Thalomid (TM); Thalomid (TN); Thalomid, Thalidomide; Thalomide; Theophilcholine; Valgis; Valgraine; Yodomin
Drug Type
Small molecular drug
Therapeutic Class
Immunosuppressive Agents
Structure
3D MOL 2D MOL
Formula
C13H10N2O4
Canonical SMILES
C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
InChI
InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
InChIKey
UEJJHQNACJXSKW-UHFFFAOYSA-N
CAS Number
CAS 50-35-1
Pharmaceutical Properties Molecular Weight 258.23 Topological Polar Surface Area 83.6
Heavy Atom Count 19 Rotatable Bond Count 1
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 4
XLogP
0.3
PubChem CID
5426
PubChem SID
10112 ,10321467 ,10524356 ,11120267 ,11120755 ,11121243 ,11121763 ,11122243 ,111716 ,11335226 ,11360465 ,11362910 ,11364734 ,11365472 ,11367296 ,11368034 ,11369858 ,11371011 ,11371012 ,11372649 ,11372899 ,11373635 ,11374612 ,11375458 ,11376196 ,11378022 ,11428259 ,11450681 ,11461437 ,11466220 ,11467340 ,11484629 ,11485800 ,11488523 ,11491530 ,11492901 ,11532929 ,12013404 ,14798889 ,17405778 ,22391552 ,398060 ,398061 ,482479 ,5642997 ,596356 ,7847819 ,7980770 ,8150004 ,8153340
ChEBI ID
CHEBI:74947
TTD Drug ID
D0U7GK

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.